Ovid Therapeutics (1OT.F) Q1 2025 Earnings

11MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.21
-0.1
0
0.11

Details

Expected EPS
-0.15453970111999998
Actual EPS
-0.1191008
Surprise EPS
0.04
Surprise Percent
+22.93%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.1191008 per share for Q1 2025.

0 Comments

Share your thoughts